Th-1 Dendritic Cell Immunotherapy Plus Standard Chemotherapy for Pancreatic Adenocarcinoma

Clinical trial NCT04157127 · RECRUITING

Trial details

NCT number: NCT04157127
Sponsor: Diakonos Oncology Corporation
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma Pancreatic Cancer Pancreatic Adenosquamous Carcinoma

Start date: 2020-08-03
Primary completion: 2026-06-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.